A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation

• Thomas Hills,

  Affiliation Department of Oncology, University of Oxford, Oxford, United Kingdom

  ⨯
• Phillip G. Jakeman,

  Affiliation Department of Oncology, University of Oxford, Oxford, United Kingdom

  ⨯
• Robert C. Carlisle,

  Affiliation Department of Biomedical Engineering, University of Oxford, Oxford, United Kingdom

  ⨯
• Paul Klenerman,

  Affiliation Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom

  ⨯
• Leonard W. Seymour ,

  * E-mail: len.seymour@oncology.ox.ac.uk

  Affiliation Department of Oncology, University of Oxford, Oxford, United Kingdom

  ⨯
• Ryan Cawood

  Affiliation Department of Oncology, University of Oxford, Oxford, United Kingdom

  ⨯